Somatostatin-28 (1-12) is a somatostatin fragment that is monitored in brain tissue to track processing of somatostatin.
Somatostatin-28 1-12 is a synthetic peptide fragment derived from the N-terminal region of the longer somatostatin-28 neuropeptide. As a truncated analog, it retains key structural motifs that contribute to somatostatin's biological activity, including its ability to interact with somatostatin receptors and modulate diverse cellular pathways. This peptide is of significant interest in biochemical and neuroendocrine research due to its role in regulating hormone secretion, neurotransmission, and cell proliferation. Its defined sequence and receptor-binding properties make it a valuable tool for elucidating the structure-function relationships of the somatostatin family and for probing the molecular mechanisms underlying peptide-receptor interactions.
Receptor Binding Studies: Somatostatin-28 1-12 is frequently employed in receptor binding assays to investigate the specificity and affinity of somatostatin receptor subtypes. By using this fragment in radioligand displacement or fluorescence-based assays, researchers can delineate the contribution of the N-terminal region to receptor recognition and activation. Such studies are essential for mapping ligand-receptor interactions, characterizing receptor pharmacology, and guiding the rational design of novel peptide analogs with tailored selectivity profiles.
Neuroendocrine Signaling Research: The peptide serves as a functional probe in neuroendocrine studies aimed at understanding the modulation of hormone secretion and neuronal signaling by somatostatin analogs. Its application allows for the dissection of signaling cascades triggered by somatostatin receptor engagement, providing insight into the regulatory mechanisms that control the release of growth hormone, insulin, glucagon, and other key endocrine factors. Utilizing this fragment in in vitro systems or ex vivo tissue preparations supports the identification of downstream effectors and signaling pathways modulated by somatostatin peptides.
Peptide Structure-Activity Relationship (SAR) Analysis: Somatostatin-28 1-12 is a critical tool in structure-activity relationship investigations, enabling systematic evaluation of how specific sequence elements contribute to biological function. Researchers can compare the activity of this N-terminal fragment to longer somatostatin peptides or modified analogs, thereby elucidating the minimal structural requirements for receptor binding and functional efficacy. Such SAR studies inform the development of optimized peptide ligands with enhanced stability, potency, or receptor subtype selectivity.
Peptide Synthesis and Analytical Method Development: The defined sequence of this fragment makes it an important reference standard in peptide synthesis and analytical method validation. It is used to optimize solid-phase peptide synthesis protocols, assess reaction yields, and calibrate analytical techniques such as HPLC, mass spectrometry, and capillary electrophoresis. By providing a model substrate, the peptide supports quality control and method development efforts in peptide chemistry laboratories.
Cellular Pathway Elucidation: In cellular and molecular biology contexts, Somatostatin-28 1-12 is utilized to dissect the intracellular pathways activated or inhibited by somatostatin receptor engagement. Application of this fragment to cultured cells or tissue explants enables the study of downstream signaling events, such as changes in cAMP levels, calcium flux, or kinase activation. These investigations contribute to a deeper understanding of the cellular responses governed by somatostatin peptides and their potential roles in cellular homeostasis, proliferation, and differentiation.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More